Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro's UK private price rose significantly from 1 September 2025, when Eli Lilly increased its list price across all doses — the highest dose moved from around £122 to around £330 per four-week pen, and typical private-clinic prices since then have ranged roughly £149 to £375 a month depending on dose and provider. That is the honest, factual answer. These are prescription-only medicines, which means any legitimate price you see should reflect a full clinical assessment by a prescriber — not just the pen itself. What that assessment includes, and what some headline prices quietly leave out, matters more than the monthly figure alone.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Eli Lilly's September 2025 price increase was substantial by any measure. Before it, the highest-dose pen carried a list price of around £122; after it, around £330. That shift fed directly into private-market pricing, which is why the figure patients see quoted today looks so different from what they may have read twelve or eighteen months ago.
The increase applies across the dose range, not just at the top. Lower doses rose proportionately, which is why a full breakdown of the new Mounjaro price list by dose is worth checking before you compare providers. Prices reported widely since September 2025 typically sit between £149 and £375 per month across all doses and providers, though these figures are hedged, individual clinic pricing varies, and some providers bundle in more than others.
Mounjaro is a prescription-only medicine regulated by the MHRA, and MHRA guidance on GLP-1 medicines for weight management makes clear these treatments are not assessed or licensed for cosmetic use. A prescriber decides suitability, not a Mounjaro price comparison.
Some providers quote only the pen. The consultation, prescription, delivery and any aftercare support may each carry a separate fee, or may simply be absent. When you add those up, the apparent saving from a lower headline price can disappear quickly.
Common extras that do not always feature in a quoted monthly figure: initial consultation fees (sometimes £30–£50 separately), prescription fees charged per issue, delivery costs that vary by speed, and clinical review before a dose increase or repeat. If a provider does not mention these, it is worth asking directly.
Details about how the actual cost of Mounjaro varies across the market (once you factor in those extras) are worth reading before committing to any service. The pen itself is only part of what clinical treatment involves.
For context on the 5mg dose specifically, the new Mounjaro 5mg price page covers that dose's position in the updated pricing picture.
At nume, one price covers everything: the consultation, the prescription, the treatment, and next-working-day tracked delivery through DPD, the kind where you get a message on your phone when the plain brown box is twenty minutes away. There are no subscription fees, no auto-renewals and no separate delivery charge added at the end. Every repeat order goes through a fresh clinical review.
We are not the cheapest option in the market, and that is a deliberate choice. Cheapest is not a race worth running with a prescription medicine. What the price buys is a real prescriber reviewing your consultation the same day, a GPhC-registered pharmacy dispensing through the licensed UK supply chain, and a clinical team available seven days a week if something feels off.
You can see current treatment pricing on the weight-loss treatments page, where consultation is free to start. Our clinical approach and the prescribers behind it are there to read if you want to know who is making the decision.
Mounjaro is a Black Triangle medicine under additional MHRA monitoring. Getting it from an unverified seller (particularly one offering prices well below the current market or advertising on social media) carries real risk. The MHRA has seized counterfeit weight-loss pens in significant quantities, including a UK site producing fake tirzepatide pens raided in late 2025. Some fake pens have contained insulin.
Any seller offering these medicines without a proper prescription and clinical assessment is operating outside the law. You can check whether a pharmacy is legitimately registered at the GPhC register, nume's registration number is 9012878. For Mounjaro specifically, the NHS tirzepatide medicines page sets out what to expect from legitimate treatment and what warning signs to watch for.
Price matters. But for a prescription medicine, the right question is not which provider is cheapest, it is which provider is safe, legitimate and will actually support you clinically. If you want a clearer picture of how the new Mounjaro prices sit relative to the wider treatment landscape, that page covers the current market context in more detail. And if someone has pointed you toward a discount code, the information on Mounjaro discount codes is worth reading first.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.